OC
PLXP

Oppenheimer & Co’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Oppenheimer & Co’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,666
Closed -$271K – 1488
2015
Q2 		$271K Sell
2,666
-1,264
-32% -$131K 0.01% 1141
2015
Q1 		$429K Buy
3,930
+959
+32% +$98.2K 0.01% 947
2014
Q4 		$271K Buy
2,971
+408
+16% +$34.8K 0.01% 1075
2014
Q3 		$204K Buy
2,563
+865
+51% +$66.1K 0.01% 1242
2014
Q2 		$132K Buy
+1,698
New +$132K ﹤0.01% 1324

Other funds holding PLXP

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Oppenheimer & Co's PLXP Position: Q3 2015 in Review

Oppenheimer & Co sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2015, closing a stake of 2,666 shares — an estimated $271K sold.

Oppenheimer & Co first reported a position in PLXP in Q2 2014 and held it in 5 quarters. The position peaked at $429K in Q1 2015. 28 funds tracked by Wall St. Rank hold PLXP as of Q3 2015.

  • Oppenheimer & Co reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 2,666 PLx Pharma Inc. Common Stock shares in Q3 2015, an estimated $271K.
  • Oppenheimer & Co first reported a position in PLx Pharma Inc. Common Stock in Q2 2014 and held it in 5 quarters.
  • Oppenheimer & Co's PLx Pharma Inc. Common Stock position peaked at $429K in Q1 2015.
  • 28 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2015.

Based on Oppenheimer & Co's 13F filing for Q3 2015, filed 13 Nov 2015.